Meinian Onehealth Healthcare Holdings (002044) Fair Value & Analysis
Healthcare · CN · Market cap 19.7B CNY
Fair value as of: Jul 21, 2026
From 24 valuation models · updated 20 days ago
Fair value updated Jul 21, 2026, revised from ¥2.99 to ¥1.60 (−46.5%) since Jun 25, 2026. Share price +9.8% over the past month.
A solid business, but screening 67% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥2.08). The favourable scenario is already priced in.
- Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range ¥3.26 – ¥18.76 · fair‑value band ¥1.30 – ¥2.08 · the ¥4.82 price screens above the ¥1.60 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Meinian Onehealth Healthcare Holdings (002044) currently trades at ¥4.82, while our model-based Fair Value estimate is ¥1.60, implying the stock looks roughly 66.8% overvalued today. The Quality Score stands at 58/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Meinian Onehealth Healthcare Holdings generated revenue of 10.2B CNY at a net margin of 3.0%. Revenue declined 9.7% year over year. It earns a return on equity of 4.7%. Net debt stands at 1.9B CNY. Fundamentals as of Jul 21, 2026
Our scenario range runs from ¥1.30 (bear case) to ¥2.08 (bull case); at ¥4.82, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 46% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -67%, 002044 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (¥7.56) versus Earnings-Based (¥1.28). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 28
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Meinian Onehealth Healthcare Holdings Co., Ltd. offers health checkup services. The company integrates health consultation, health assessment, and health management services.
Full company description
Meinian Onehealth Healthcare Holdings Co., Ltd. offers health checkup services. The company integrates health consultation, health assessment, and health management services. It also provides professional prevention, health protection, nutrition and health management consulting, health checkup, medical technology, information technology, health advisory, medical care, and insurance brokerage services. In addition, the company is involved in investment management, physical examination management, software development, and sales. Further, it offers research and experimental development services; sells medicines and medical devices; and engages in financial leasing, factoring, consulting, and pharmaceutical businesses. The company was founded in 1991 and is headquartered in Shanghai, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Meinian Onehealth Healthcare Holdings reported revenue of ¥10.4B in FY2025 versus ¥9.2B in FY2021, a compound +3.0%/yr. Reported net income was ¥285M in FY2025, compounding +46.7%/yr from FY2021.
002044 screens 67% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Meinian Onehealth Healthcare Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Meinian Onehealth Healthcare Holdings (002044) overvalued or undervalued?
What is the fair value of 002044?
What is the quality score of 002044?
What is the revenue of Meinian Onehealth Healthcare Holdings (002044)?
What is the net profit margin of 002044?
Does Meinian Onehealth Healthcare Holdings pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Meinian Onehealth Healthcare Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.